Information about Botox by Allergan

Vistabel is a well-known brand of botulinum toxin type A used in aesthetic medicine. It is commonly used by doctors and clinics for anti-wrinkle injections and for the treatment of excessive sweating (hyperhidrosis).

History of Botox

Botulinum toxin has been used in medicine since the 1970s. It was originally developed by ophthalmologist Alan B. Scott while researching treatments for conditions such as strabismus (crossed eyes) and blepharospasm (involuntary eyelid spasms). He founded Oculinum Inc., which produced the first form of botulinum toxin for clinical use.

In 1986, the pharmaceutical company Allergan acquired Oculinum Inc. and renamed the product Botox. Since then, Allergan has continued to research both medical and cosmetic applications. In 2002, botulinum toxin received approval from the U.S. Food and Drug Administration (FDA) for the cosmetic treatment of frown lines. Botox is a brand name for botulinum toxin type A.

The History of Allergan

Allergan Pharmaceuticals Inc. was founded in 1948 by pharmacist Gavin S. Herbert. The company focused on developing specialised pharmaceutical products. In 1953, it introduced one of the first cortisone eye drops for the treatment of allergies and inflammation.

Following the acquisition of Oculinum Inc. in 1986, Allergan further developed botulinum toxin for both therapeutic and aesthetic use. Over time, it became one of the most widely used treatments in aesthetic medicine. In 2020, Allergan was acquired by AbbVie. Today, its headquarters are in Dublin, Ireland, and manufacturing takes place in Westport, Ireland.

Approval and use

Botulinum toxin received its first FDA approval in 1989. Since then, it has been widely used across medical and aesthetic fields. In aesthetic practice, it is commonly used to reduce the appearance of dynamic lines such as frown lines. Results are temporary and vary between individuals. Treatments should always be carried out by a qualified and registered medical professional.

Vistabel: cosmetic brand name

Vistabel is the brand name used in Europe for the cosmetic use of botulinum toxin developed by Allergan. It is specifically indicated for aesthetic treatments such as glabellar lines.

Unique Features of Vistabel

In June 2019, Allergan announced in a press release that over 100 million vials of Botox had been produced. The company also stated that its safety profile has been evaluated in numerous clinical studies.

Botulinum toxin products are manufactured in Westport, on the west coast of Ireland. The facility operates under strict pharmaceutical standards, including controlled cleanroom environments designed to maintain product quality. Each vial undergoes inspection as part of the manufacturing process.

Certifications of Vistabel

Botulinum toxin type A has been approved for cosmetic use in various regions, including approval by the U.S. Food and Drug Administration (FDA) for the treatment of frown lines.

“After studying this medicine for decades, we have developed a broad understanding of its mechanism of action and safety profile,” stated Mitchell Brin, SVP Global Drug Development and Chief Scientific Officer at Allergan, in a 2019 press release.

Other Medical Activities of Allergan

In addition to botulinum toxin products, Allergan develops a range of medicines and medical devices across multiple therapeutic areas, including immunology and neurology.

The Allergan Aesthetics division also includes products such as hyaluronic acid-based dermal fillers and other aesthetic treatments.

Find a clinic offering Vistabel by Allergan

Enter your location to compare clinics and book a consultation with a qualified and registered medical professional experienced in anti-wrinkle injections.